For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
CryoPort Inc (NASDAQ: CYRX) closed the day trading at $7.50 up 0.13% from the previous closing price of $7.49. In other words, the price has increased by $0.13 from its previous closing price. On the day, 0.22 million shares were traded. CYRX stock price reached its highest trading level at $7.58 during the session, while it also had its lowest trading level at $7.31.
Ratios:
For a better understanding of CYRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.32 and its Current Ratio is at 5.70. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.51.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on December 19, 2024, initiated with a Buy rating and assigned the stock a target price of $11.
On August 07, 2024, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $20 to $8.
B. Riley Securities Upgraded its Neutral to Buy on July 31, 2024, whereas the target price for the stock was revised from $19 to $15.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 02 ’24 when Mandalam Ramkumar sold 7,369 shares for $7.46 per share. The transaction valued at 54,978 led to the insider holds 59,497 shares of the business.
Hariri Robert J sold 2,500 shares of CYRX for $16,200 on Nov 21 ’24. The Director now owns 20,561 shares after completing the transaction at $6.48 per share. On Dec 02 ’24, another insider, RAMKUMAR MANDALAM, who serves as the Director of the company, bought 7,369 shares for $7.08 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 370729504 and an Enterprise Value of 363704384. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.64 while its Price-to-Book (P/B) ratio in mrq is 0.96. Its current Enterprise Value per Revenue stands at 1.609 whereas that against EBITDA is -9.235.
Stock Price History:
The Beta on a monthly basis for CYRX is 1.59, which has changed by -0.49221396 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $20.10, while it has fallen to a 52-week low of $5.32. The 50-Day Moving Average of the stock is -2.48%, while the 200-Day Moving Average is calculated to be -21.15%.
Shares Statistics:
Over the past 3-months, CYRX traded about 381.95K shares per day on average, while over the past 10 days, CYRX traded about 289330 shares per day. A total of 49.43M shares are outstanding, with a floating share count of 47.59M. Insiders hold about 3.72% of the company’s shares, while institutions hold 95.32% stake in the company. Shares short for CYRX as of 1735603200 were 2075597 with a Short Ratio of 5.43, compared to 1732838400 on 2501805. Therefore, it implies a Short% of Shares Outstanding of 2075597 and a Short% of Float of 5.050000000000001.
